UBS Group’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

UBS Group’s Portfolio CDIOW Stock Details CDIOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$89	Buy	5,561 +1,639	+42%	+$37	﹤0.01%	10135
2025 Q4	$102	Buy	3,922 +3,771	+2,497%	+$80	﹤0.01%	10182
2025 Q3	$3	Sell	151 -774	-84%	-$13	﹤0.01%	10248
2025 Q2	$15	Sell	925 -226	-20%	-$5	﹤0.01%	10135
2025 Q1	$46	Buy	+1,151	New	+$70	﹤0.01%	10022
2024 Q4	–	Sell	-9,737	Closed	-$380	–	9962
2024 Q3	$380	Sell	9,737 -264	-3%	-$10	﹤0.01%	8966
2024 Q2	$390	Buy	10,001 +4,875	+95%	+$296	﹤0.01%	8943
2024 Q1	$543	Buy	5,126 +4,208	+458%	+$631	﹤0.01%	8489
2023 Q4	$160	Buy	918 +771	+524%	+$77	﹤0.01%	8856
2023 Q3	$5	Buy	+147	New	+$16	﹤0.01%	9272
2023 Q2	–	Sell	-622	Closed	-$199	–	8980
2023 Q1	$199	Buy	622 +570	+1,096%	+$134	﹤0.01%	9140
2022 Q4	$3	Buy	52 +40	+333%	+$5	﹤0.01%	10635
2022 Q3	$0	Sell	12 -88	-88%	-$12	﹤0.01%	10377
2022 Q2	$0	Buy	+100	New	+$19	﹤0.01%	10359

Other funds holding CDIOW

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group's CDIOW Position: Q1 2026 in Review

UBS Group increased its Cardio Diagnostics Holdings Inc Warrant (CDIOW) stake by 42% in Q1 2026, buying an estimated $37 and bringing the position to 5,561 shares worth $89. The position accounts for ﹤0.01% of the portfolio, ranked #10135.

UBS Group first reported a position in CDIOW in Q2 2022 and has held it in 14 quarters since. The position peaked at $543 in Q1 2024. 7 funds tracked by Wall St. Rank hold CDIOW as of Q1 2026.

UBS Group held 5,561 shares of Cardio Diagnostics Holdings Inc Warrant worth $89 as of Q1 2026.
UBS Group bought 1,639 Cardio Diagnostics Holdings Inc Warrant shares in Q1 2026, an estimated $37.
Cardio Diagnostics Holdings Inc Warrant made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10135 holding.
UBS Group first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q2 2022 and has held it in 14 quarters since.
UBS Group's Cardio Diagnostics Holdings Inc Warrant position peaked at $543 in Q1 2024.
7 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.